Tags

Type your tag names separated by a space and hit enter

[Catheter ablation of accessory atrioventricular conduction pathways in all locations--consecutive results of a new curative therapy of paroxysmal supraventricular tachycardia].
Wien Klin Wochenschr 1996; 108(7):201-9WK

Abstract

Accessory atrioventricular pathways are a frequent cause of paroxysmal supraventricular tachycardias. This study analyses our results with a recently developed therapeutic approach-radiofrequency (RF) catheter ablation. This was applied in 150 consecutive patients (97 men, 53 women, mean age 42 +/- 15 years) with a total of 159 accessory pathways in all locations. All but 4 patients were symptomatic, with a spectrum ranging from palpitations (146 patients), syncope (39 patients) to aborted sudden death (2 patients). Prior to ablation, 115 patients had received long-term treatment with up to 4 antiarrhythmic drugs unsuccessfully. The mean number of applied current pulses was 12 +/- 14, and the mean cumulative procedure duration was 256 +/- 243 minutes, with a cumulative fluoroscopy time of 49 +/- 72 minutes. Patients with left-sided pathways were approached via the retrograde aortic approach in 88/90 cases. One-hundred fifteen patients were treated in a single session, repeat sessions were required in the remaining 35 patients. The predominant sites of interruption of right-sided and left-sided accessory pathways were their atrial and ventricular insertion, respectively. Long-term cure was achieved in 141 patients (94%), non-life-threatening complications were observed in 3 patients (2%). These results compare well with published studies on large patient collectives and demonstrate that RF catheter ablation, which is highly cost effective, is the therapy of choice to cure symptomatic patients with accessory atrioventricular pathways in all locations.

Authors+Show Affiliations

Ludwig-Boltzmann-Institut für Arrhythmieforschung, Wilhelminenspital der Stadt Wien.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

8677664

Citation

Hatala, R, et al. "[Catheter Ablation of Accessory Atrioventricular Conduction Pathways in All Locations--consecutive Results of a New Curative Therapy of Paroxysmal Supraventricular Tachycardia]." Wiener Klinische Wochenschrift, vol. 108, no. 7, 1996, pp. 201-9.
Hatala R, Kaltenbrunner W, Merl O, et al. [Catheter ablation of accessory atrioventricular conduction pathways in all locations--consecutive results of a new curative therapy of paroxysmal supraventricular tachycardia]. Wien Klin Wochenschr. 1996;108(7):201-9.
Hatala, R., Kaltenbrunner, W., Merl, O., Elkaheli, T., Freihoff, F., Supper, W., & Steinbach, K. (1996). [Catheter ablation of accessory atrioventricular conduction pathways in all locations--consecutive results of a new curative therapy of paroxysmal supraventricular tachycardia]. Wiener Klinische Wochenschrift, 108(7), pp. 201-9.
Hatala R, et al. [Catheter Ablation of Accessory Atrioventricular Conduction Pathways in All Locations--consecutive Results of a New Curative Therapy of Paroxysmal Supraventricular Tachycardia]. Wien Klin Wochenschr. 1996;108(7):201-9. PubMed PMID: 8677664.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Catheter ablation of accessory atrioventricular conduction pathways in all locations--consecutive results of a new curative therapy of paroxysmal supraventricular tachycardia]. AU - Hatala,R, AU - Kaltenbrunner,W, AU - Merl,O, AU - Elkaheli,T, AU - Freihoff,F, AU - Supper,W, AU - Steinbach,K, PY - 1996/1/1/pubmed PY - 1996/1/1/medline PY - 1996/1/1/entrez SP - 201 EP - 9 JF - Wiener klinische Wochenschrift JO - Wien. Klin. Wochenschr. VL - 108 IS - 7 N2 - Accessory atrioventricular pathways are a frequent cause of paroxysmal supraventricular tachycardias. This study analyses our results with a recently developed therapeutic approach-radiofrequency (RF) catheter ablation. This was applied in 150 consecutive patients (97 men, 53 women, mean age 42 +/- 15 years) with a total of 159 accessory pathways in all locations. All but 4 patients were symptomatic, with a spectrum ranging from palpitations (146 patients), syncope (39 patients) to aborted sudden death (2 patients). Prior to ablation, 115 patients had received long-term treatment with up to 4 antiarrhythmic drugs unsuccessfully. The mean number of applied current pulses was 12 +/- 14, and the mean cumulative procedure duration was 256 +/- 243 minutes, with a cumulative fluoroscopy time of 49 +/- 72 minutes. Patients with left-sided pathways were approached via the retrograde aortic approach in 88/90 cases. One-hundred fifteen patients were treated in a single session, repeat sessions were required in the remaining 35 patients. The predominant sites of interruption of right-sided and left-sided accessory pathways were their atrial and ventricular insertion, respectively. Long-term cure was achieved in 141 patients (94%), non-life-threatening complications were observed in 3 patients (2%). These results compare well with published studies on large patient collectives and demonstrate that RF catheter ablation, which is highly cost effective, is the therapy of choice to cure symptomatic patients with accessory atrioventricular pathways in all locations. SN - 0043-5325 UR - https://www.unboundmedicine.com/medline/citation/8677664/[Catheter_ablation_of_accessory_atrioventricular_conduction_pathways_in_all_locations__consecutive_results_of_a_new_curative_therapy_of_paroxysmal_supraventricular_tachycardia]_ DB - PRIME DP - Unbound Medicine ER -